Xilio Therapeutics

Performance

About Xilio Therapeutics

Xilio Therapeutics is a biotechnology company focused on developing tumor-activated immunotherapies to transform cancer treatment. The company specializes in tumor-selective activation using a proprietary platform to create masked biologics, including masked bispecifics and masked T cell engagers, with the aim of concentrating anti-tumor activity in the tumor microenvironment while reducing systemic toxicity. Their pipeline spans clinical and preclinical immunotherapies targeting oncology indications, designed to improve therapeutic efficacy and safety for cancer patients. The company emphasizes immuno-oncology and tumor-specific strategies to advance cancer therapies.